According to the semi-quantitative results of IHC, we found that the expression of IGF2BP2 increased gradually in epithelial hyperplasia, epithelial dysplasia and squamous cell carcinoma (SCC) (all P<0.01) (Figure 3A, Table 3). This evidence concerns the gene IGF2BP2 and intraepithelial neoplasia.